Jordi
Vila Estapé
Publicaciones en las que colabora con Jordi Vila Estapé (33)
2024
-
In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 69-77
2022
2019
2018
-
Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain
International Journal of Antimicrobial Agents, Vol. 51, Núm. 3, pp. 511-515
-
Evolution of the Quorum network and the mobilome (plasmids and bacteriophages) in clinical strains of Acinetobacter baumannii during a decade
Scientific Reports, Vol. 8, Núm. 1
-
Relationship between the Quorum network (sensing/quenching) and clinical features of pneumonia and bacteraemia caused by A. Baumannii
Frontiers in Microbiology, Vol. 9
2017
-
High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 12, pp. 3277-3282
-
Overproduction of Outer membrane protein a by Acinetobacter baumannii as a risk factor for nosocomial pneumonia, bacteremia, and mortality rate increase
Journal of Infectious Diseases, Vol. 215, Núm. 6, pp. 966-974
-
Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme
PLoS ONE, Vol. 12, Núm. 3
2016
-
Acinetobacter baumannii in critically ill patients: Molecular epidemiology, clinical features and predictors of mortality
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 9, pp. 551-558
-
Genomic evolution of two Acinetobacter baumannii clinical strains from ST-2 clones isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010)
Genome Announcements, Vol. 4, Núm. 5
2015
-
Reduced susceptibility to biocides in Acinetobacter baumannii: Association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps
Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 12, pp. 3222-3229
2014
-
Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 10, pp. 2629-2633
-
Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. S4, pp. 24-32
-
Epidemiologic and clinical impact of acinetobacter baumannii colonization and infection: A reappraisal
Medicine (United States), Vol. 93, Núm. 5, pp. 202-210
-
Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 11, pp. 3119-3126
-
Nosocomial outbreak of a multiresistant acinetobacter baumannii expressing OXA-23 carbapenemase in Spain
Microbial Drug Resistance, Vol. 20, Núm. 4, pp. 259-263
2013
-
Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 1, pp. 4-9
-
Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii
Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 11, pp. 5247-5257